Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions. OPTION AND LICENSE...Option and License Agreement • November 2nd, 2021 • Voyager Therapeutics, Inc. • Biological products, (no disgnostic substances)
This OPTION AND LICENSE AGREEMENT (the “Agreement”) is entered into and made effective as of October 1, 2021 (the “Effective Date”), by and between Voyager Therapeutics, Inc., a Delaware corporation, having its principal place of business at 75 Sidney Street, Cambridge, MA 02139 (“Voyager”), and Pfizer Inc., a Delaware corporation, having its principal place of business at 235 East 42nd Street NY, NY 10017 (“Pfizer”). Voyager and Pfizer are referred to herein individually as a “Party” and collectively as the “Parties”.
SUBLEASE AGREEMENTLease Agreement • November 2nd, 2021 • Voyager Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS SUBLEASE AGREEMENT (this “Sublease”) is made and entered into as of September 3, 2021 (the “Effective Date”), by and between VOYAGER THERAPEUTICS, INC., a Delaware corporation (“Sublandlord”), and BIONTECH US INC, a Delaware corporation (“Subtenant”).
